{"schema_version":"1","generated_at":"2026-11-10T17:55:33.638Z","data_as_of":null,"url":"https://www.findmykol.com/kol/oyebimpe-adesina","json_url":"https://www.findmykol.com/kol/oyebimpe-adesina/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"oyebimpe-adesina","name":"Oyebimpe Adesina","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Seattle","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1184934770","orcid":"0000-0002-3082-9114","openalex":"A5090897681"},"summary":"Oyebimpe Adesina is an Oncology physician. OpenAlex indexes 32 publications with 559 citations (h-index 9); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":32,"cited_by_count":559,"h_index":9,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06016634","title":"Alendronate for Osteonecrosis in Adults With Sickle Cell Disease","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of California, Davis","source_url":"https://clinicaltrials.gov/study/NCT06016634","trial_url":"https://www.findmykol.com/trial/NCT06016634"},{"nct":"NCT05283148","title":"Sickle Cell Disease (SCD) Bone Pain Study","phase":"NA","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"University of California, Davis","source_url":"https://clinicaltrials.gov/study/NCT05283148","trial_url":"https://www.findmykol.com/trial/NCT05283148"}],"source":"trials"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Cancer & immunology","share_pct":100,"classes_total":1,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":100,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":32,"shown":5,"withheld":27,"matched_by":"OpenAlex author record","recent":[{"title":"Prevalence of Low Bone Mineral Density Increases With Age in Sickle Cell Disease","year":2026,"journal":"eJHaem","source_url":"https://doi.org/10.1002/jha2.70306","status":"verified"},{"title":"PB1675 Association of 30-day mortality and inpatient admission in patients with cancer-associated pulmonary embolism presenting to the emergency department in California","year":2026,"journal":"Research and Practice in Thrombosis and Haemostasis","source_url":"https://doi.org/10.1016/j.rpth.2026.104537","status":"verified"},{"title":"Identification of Clinical Sub‐Phenotypes of Sickle Cell Disease Using Latent Class Analysis","year":2026,"journal":"PubMed Central","source_url":"https://doi.org/10.1002/ajh.70459","status":"verified"},{"title":"Low bone mineral density and pain impact in adults with sickle cell disease","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025015957","status":"verified"},{"title":"High variation of inpatient admission rates between hospitals for cancer-associated pulmonary embolism in California","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-705","status":"verified"}],"source":"works"},"contact":{"address_1":"825 EASTLAKE AVE E","address_2":"G3200","city":"Seattle","state":"WA","zip":"981094405","phone":"206-606-1621","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1184934770","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":27}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-04-20","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}